Overview

Insulin Delivery Devices Market is poised to value over USD 18.25 billion by 2027 end at a CAGR of over 8.9% during the forecast period 2020 to 2027

An increase in the prevalence of diabetes, technological advancements in the diabetes monitoring devices and the dependance on insulin thereapy in order to adminster diabtes are some of the primary factors responsible for the poliferation of the insulin delivery devices market.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Insulin Delivery Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of Insulin Delivery Devices Market.
According to the research study conducted by FutureWise research analysts, the Insulin Delivery Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Insulin Delivery Devices Market are:

  • Becton, Dickinson and Company
  • Novo Nordisk A/S 
  • Ypsomed Holding AG
  • Medtronic plc 
  • Animas Corporation
  • Tandem Diabetes Care, Inc.
  • Sanofi
  • Biocon Ltd.
  • Eli Lilly and Company 
  • Insulet Corporation  

(Note: The list of the major players will be updated with the latest market scenario and trends)

Insulin Delivery Devices Market

Insulin Delivery Devices Market Segmentation:

By Type

  • Pens
      o Reusable Pens
      o Disposable Pens
  • Pumps
      o External/Tethered Pumps
      o Patch Pumps
  • Pen Needles
      o Standard Pen Needles
      o Safety Pen Needles
  • Syringes
  • Other Devices

By End User

  • Patients/Homecare
  • Hospitals & Clinics

By Region

  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

Competitive Landscape:

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting the market growth

Objectives of the Study:

  • To provide with an exhaustive analysis on the Insulin Delivery Devices Market By Type, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with the purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to sales@futurewiseresearch.com

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics